Officials spar over benefits and risks of biotechnology.
States-parties to the Biological Weapons Convention agree on a financial fix, but little else.
One concern is the potential abuse of gene-editing technology.
States-parties to the Biological Weapons Convention (BWC), meeting in Geneva on Dec. 4-8, reached a last-minute accord on a substantive three-year work program leading to the 2021 review conference.
Iran’s demands on verification talks thwart agreement on steps to strengthen biological weapons ban.
The Biological Weapons Convention comes up for review in November. In Geneva, the states-parties debated what needs to be done to improve the treaty, which prohibits development and production of biological weapons.